mhurhangee/ep-ind-claims huggingface dataset:
A method for recovering erroneous data stored in a FLASH chip of a solid state disk wherein the FLASH chip is divided into a plurality of storage blocks and each storage block is formed by a plurality of pages, each page includes primary data space and out of band, OOB, space where the OOB space is used to store error checking and correction, ECC, data, the method comprising: when data in a storage block that is comprised in the solid state disk is read, performing a first error check on data on a certain page of the storage block to acquire erroneous data on the page; if a first number of errors of the erroneous data on the page is smaller than or equal to a preset first threshold, performing ECC recovery on the data on the page; characterized in that the method further comprises: if the first number of errors of the erroneous data is greater than the preset first threshold, acquiring data from spare space of the OOB space that does not actually store the ECC data according to a storage position of the erroneous data on the page and a fixed entry corresponding to the storage block, and replacing the erroneous data on the page with the acquired data, wherein the fixed entry comprises a storage position of each data stored in the spare space. when data in a storage block that is comprised in the solid state disk is read, performing a first error check on data on a certain page of the storage block to acquire erroneous data on the page; if a first number of errors of the erroneous data on the page is smaller than or equal to a preset first threshold, performing ECC recovery on the data on the page; characterized in that the method further comprises: if the first number of errors of the erroneous data is greater than the preset first threshold, acquiring data from spare space of the OOB space that does not actually store the ECC data according to a storage position of the erroneous data on the page and a fixed entry corresponding to the storage block, and replacing the erroneous data on the page with the acquired data, wherein the fixed entry comprises a storage position of each data stored in the spare space.
A power assembly for a variable speed drive system comprising: a film capacitor; at least one cooling device mounted on the film capacitor, the at least one cooling device operating as a heat sink for the film capacitor and being configured to circulate a cooling fluid through the at least one cooling device; at least one electrical component mounted on the at least one cooling device, the at least one electrical component being cooled by the circulating cooling fluid in the at least one cooling device, wherein the at least one cooling device comprises a plastic material and wherein the film capacitor has a plurality of mounting apertures disposed on the film capacitor, the at least one cooling device mounted on the film capacitor using the plurality of mounting apertures. a film capacitor; at least one cooling device mounted on the film capacitor, the at least one cooling device operating as a heat sink for the film capacitor and being configured to circulate a cooling fluid through the at least one cooling device; at least one electrical component mounted on the at least one cooling device, the at least one electrical component being cooled by the circulating cooling fluid in the at least one cooling device, wherein the at least one cooling device comprises a plastic material and wherein the film capacitor has a plurality of mounting apertures disposed on the film capacitor, the at least one cooling device mounted on the film capacitor using the plurality of mounting apertures.
A combination therapy, comprising (i) a viral vector comprising a transgene encoding for a protein of interest, and (ii) an extracellular vesicle -based vector comprising the transgene in the form of mRNA, circular RNA (circRNA), mini-circle, plasmid DNA (pDNA) or a linear DNA polynucleotide for use in medicine, wherein the EV-based vector is produced from a cell source, such as a cell line, that is allogenic in nature to the patient to be treated, and wherein the transgene is initially administered using the viral vector and subsequently administered using the EV- based vector; further wherein the viral vector is an adeno-associated virus -based vector.
A low alloy steel for oil country tubular goods having a chemical composition consisting of, by mass percent, C: 0.56 to 1.00%, Si: 0.05 to 0.50%, Mn: 0.05 to 1.00%, P: at most 0.025%, S: at most 0.010%, Al: 0.005 to 0.100%, Mo: 0.40 to 1.00%, V: 0.07 to 0.30%, O: at most 0.010%, N: at most 0.0300%, and optionally one or more selected from the group consisting of Cr: at most 2.00%, Nb: at most 0.100%, Ti: at most 0.100%, Zr: at most 0.100%, Ca: at most 0.0100%, and B: at most 0.0030%, the balance being Fe and impurities, wherein the yield stress thereof is at least 862 MPa; the half-value width of a crystal surface obtained by X-ray diffraction is at most 0.50°; and the aspect ratio of carbides is 0.45 or above.
A packaging material for a lithium ion battery, the packaging material comprising: a base material layer that is formed from a film obtained by biaxially stretching a multi-layered coextruded film including a first thermoplastic resin layer containing an aromatic polyester resin and being disposed at an outer side thereof, a second thermoplastic resin layer containing a modified thermoplastic resin that is graft-modified with one or more unsaturated carboxylic acid derivative components selected from the group consisting of unsaturated carboxylic acid, acid anhydride of the unsaturated carboxylic acid, and ester of the unsaturated carboxylic acid, and a third thermoplastic resin layer containing a polyamide resin, wherein the second thermoplastic resin layer is provided between the first thermoplastic resin layer and the third thermoplastic resin layer; a metal foil layer that is laminated on one surface of the base material layer; an optional outer adhesive layer that bonds the base material layer and the metal foil layer; an anti-corrosion-treated layer that is laminated on the metal foil layer; an inner adhesive layer that is laminated on the anti-corrosion-treated layer; and a sealant layer that is laminated on the inner adhesive layer. a base material layer that is formed from a film obtained by biaxially stretching a multi-layered coextruded film including a first thermoplastic resin layer containing an aromatic polyester resin and being disposed at an outer side thereof, a second thermoplastic resin layer containing a modified thermoplastic resin that is graft-modified with one or more unsaturated carboxylic acid derivative components selected from the group consisting of unsaturated carboxylic acid, acid anhydride of the unsaturated carboxylic acid, and ester of the unsaturated carboxylic acid, and a third thermoplastic resin layer containing a polyamide resin, wherein the second thermoplastic resin layer is provided between the first thermoplastic resin layer and the third thermoplastic resin layer; a metal foil layer that is laminated on one surface of the base material layer; an optional outer adhesive layer that bonds the base material layer and the metal foil layer; an anti-corrosion-treated layer that is laminated on the metal foil layer; an inner adhesive layer that is laminated on the anti-corrosion-treated layer; and a sealant layer that is laminated on the inner adhesive layer.
A compound of formula or a salt thereof, wherein R1 is hydrogen or C 1 -C 6 -alkyl, R3 is -NO 2 or -NR'R", wherein R' and R" are independently of each other hydrogen or a nitrogen protecting group, and R4 is selected from hydrogen, C 1 -C 6 -carbonyl, C 1 -C 6 -alkoxycarbonyl and a sulphonyl group, wherein the nitrogen protecting group is selected from the group consisting of C 1 -C 6 -alkyl, which is unsubstituted or mono-, di- or tri-substituted by tri-C 1 -C 6 -alkylsilylC 1 -C 7 -alkoxy, C 6 -C 10 -aryl, or a heterocyclic group being a mono-, bi- or tricyclic ring system with 5 to 14 ring atoms and 1 to 4 heteroatoms independently selected from N, O, S, S or S 2, wherein the aryl ring or the heterocyclic group is unsubstituted or substituted by one, two or three residues, selected from the group consisting of C 1 -C 7 -alkyl, hydroxyl, C 1 -C 7 -alkoxy, C 2 -C 8 -alkanoyl-oxy, halogen, nitro, cyano, and CF 3; C 6 -C 10 -aryl-C 1 -C 2 -alkoxycarbonyl; C 2 -C 10 -alkenyloxycarbonyl; C 1 -C 6 -alkylcarbonyl; C 6 -C 10 -arylcarbonyl; C 1 -C 6 -alkoxycarbonyl; C 6 -C 10 -aryl-C 1 -C 6 -alkoxycarbonyl; allyl; cinnamyl; sulfonyl; sulfenyl; succinimidyl, and silyl, wherein each silyl group is a SiR11R12R13 group, wherein R11, R12 and R13 are, independently of each other, C 1 -C 7 -alkyl, C 6 -C 10 -aryl or phenyl-C 1- C 4 -alkyl. wherein R1 is hydrogen or C 1 -C 6 -alkyl, R3 is -NO 2 or -NR'R", wherein R' and R" are independently of each other hydrogen or a nitrogen protecting group, and R4 is selected from hydrogen, C 1 -C 6 -carbonyl, C 1 -C 6 -alkoxycarbonyl and a sulphonyl group, wherein the nitrogen protecting group is selected from the group consisting of C 1 -C 6 -alkyl, which is unsubstituted or mono-, di- or tri-substituted by tri-C 1 -C 6 -alkylsilylC 1 -C 7 -alkoxy, C 6 -C 10 -aryl, or a heterocyclic group being a mono-, bi- or tricyclic ring system with 5 to 14 ring atoms and 1 to 4 heteroatoms independently selected from N, O, S, S or S 2, wherein the aryl ring or the heterocyclic group is unsubstituted or substituted by one, two or three residues, selected from the group consisting of C 1 -C 7 -alkyl, hydroxyl, C 1 -C 7 -alkoxy, C 2 -C 8 -alkanoyl-oxy, halogen, nitro, cyano, and CF 3; C 6 -C 10 -aryl-C 1 -C 2 -alkoxycarbonyl; C 2 -C 10 -alkenyloxycarbonyl; C 1 -C 6 -alkylcarbonyl; C 6 -C 10 -arylcarbonyl; C 1 -C 6 -alkoxycarbonyl; C 6 -C 10 -aryl-C 1 -C 6 -alkoxycarbonyl; allyl; cinnamyl; sulfonyl; sulfenyl; succinimidyl, and silyl, wherein each silyl group is a SiR11R12R13 group, wherein R11, R12 and R13 are, independently of each other, C 1 -C 7 -alkyl, C 6 -C 10 -aryl or phenyl-C 1- C 4 -alkyl.
Pharmaceutical composition consisting of plasminogen and a pharmaceutically acceptable carrier, excipient or stabilizer, for use in the treatment of an arterial and venous thrombosis in a subject.
A network attach method for a relay node, RN, comprising: accessing, by the RN, a cell; obtaining, by the RN, a list of base station cells that support a relay function and allow being accessed by the RN; and characterized by: determining, by the RN according to indication information carried in a radio resource configuration message sent by a base station of the cell, that a mobility management device serving the RN supports a relay function, wherein the indication information is used to indicate that the mobility management device serving the RN supports a relay function; and when the cell accessed by the RN belongs to the list of base station cells that support a relay function, and the mobility management device serving the RN supports a relay function, determining, by the RN, not to leave the accessed cell. accessing, by the RN, a cell; obtaining, by the RN, a list of base station cells that support a relay function and allow being accessed by the RN; and characterized by: determining, by the RN according to indication information carried in a radio resource configuration message sent by a base station of the cell, that a mobility management device serving the RN supports a relay function, wherein the indication information is used to indicate that the mobility management device serving the RN supports a relay function; and when the cell accessed by the RN belongs to the list of base station cells that support a relay function, and the mobility management device serving the RN supports a relay function, determining, by the RN, not to leave the accessed cell. determining, by the RN according to indication information carried in a radio resource configuration message sent by a base station of the cell, that a mobility management device serving the RN supports a relay function, wherein the indication information is used to indicate that the mobility management device serving the RN supports a relay function; and when the cell accessed by the RN belongs to the list of base station cells that support a relay function, and the mobility management device serving the RN supports a relay function, determining, by the RN, not to leave the accessed cell.
Method for the decontamination of a radioactively contaminated metal surface, comprising the step of: - bringing at least a portion of the metal surface into contact with a decontamination solution comprising a complexing agent selected from hydrofluoric acid, methanesulfonic acid and carboxylic acids such as nitriloacetic acid, ethylenediaminetetraacetic acid, oxalic acid, tartaric acid, citric acid and picolinic acid and the salts thereof, and an ion of a transition metal. - bringing at least a portion of the metal surface into contact with a decontamination solution comprising a complexing agent selected from hydrofluoric acid, methanesulfonic acid and carboxylic acids such as nitriloacetic acid, ethylenediaminetetraacetic acid, oxalic acid, tartaric acid, citric acid and picolinic acid and the salts thereof, and an ion of a transition metal.
Method for determining a set of encoding formats usable by a terminal to establish communications via a communication network, the method being characterized in that it includes the following steps, implemented by a communication device: - obtaining, from a server, a first set of coding formats permitted on the communication network, each format of the set being associated with a type of access network and with a type of communication service, - obtaining a second set of coding formats supported by a terminal that registers or is registered on said communication network, a type of access network and a type of communication service which are used by the terminal, - determining a third set of coding formats usable, when said third set is not empty, by the terminal to establish communications via said communication network via an access network, the third set corresponding to a set of coding formats supported by the terminal and permitted by the network given the type of access network and the type of communication service used by the terminal, and - deregistering the terminal or downloading, onto the terminal, an executable module comprising instructions for implementing a coding format permitted by the network when the third set of encoding formats is empty. - obtaining, from a server, a first set of coding formats permitted on the communication network, each format of the set being associated with a type of access network and with a type of communication service, - obtaining a second set of coding formats supported by a terminal that registers or is registered on said communication network, a type of access network and a type of communication service which are used by the terminal, - determining a third set of coding formats usable, when said third set is not empty, by the terminal to establish communications via said communication network via an access network, the third set corresponding to a set of coding formats supported by the terminal and permitted by the network given the type of access network and the type of communication service used by the terminal, and - deregistering the terminal or downloading, onto the terminal, an executable module comprising instructions for implementing a coding format permitted by the network when the third set of encoding formats is empty.
Brewing apparatus for extracting a portion capsule, having a first brewing chamber element and a second brewing chamber element, wherein the first and/or the second brewing chamber element (3, 4) are/is movable in an axial direction between a loading position, in which the first and the second brewing chamber element (3, 4) are spaced apart from each other, and an extraction position, in which the first and the second brewing chamber element (3, 4) form a substantially closed brewing chamber, wherein the brewing apparatus is designed such that, when the first and/or the second brewing chamber element (3, 4) is/are moved from the loading position into the extraction position, the portion capsule is first of all perforated by the at least one first perforation means of the first brewing chamber element and only then is perforated by at least one second perforation means of the second brewing chamber element, wherein the at least one first perforation means is in the form of a perforation point which protrudes from the first brewing chamber element substantially in the direction of the second brewing chamber element, wherein the first brewing chamber element has, on an end side facing the second brewing chamber element, a perforation element which comprises a central surface region that is connected integrally, around its circumference, to the at least one perforation means, characterized in that the at least one perforation point has a substantially linear cross section, formed in a rectilinear manner, in the axial direction, wherein the perforation element is produced by bending the at least one first perforation means with respect to the surface region by buckling, wherein the at least one first perforation means protrudes from the surface region at right angles.
An Information Handling System, IHS,, comprising: a processor; one or more sensors; a first display and a second display; and a memory coupled to the processor, the memory having program instructions stored thereon that, upon execution by the processor, cause the IHS to: identify an arrangement of a second display relative to a first display; identify, using the one or more sensors, a position of a keyboard relative to the second display, by determining that the keyboard is placed atop or next to a display surface of the second display; and modify a Graphical User Interface, GUI, provided by the second display in response to: i) the arrangement; ii) the position; and iii) an active application, by rendering a first bar including dynamically selected items associated with the active application on the second display along the keyboard. a processor; one or more sensors; a first display and a second display; and a memory coupled to the processor, the memory having program instructions stored thereon that, upon execution by the processor, cause the IHS to: identify an arrangement of a second display relative to a first display; identify, using the one or more sensors, a position of a keyboard relative to the second display, by determining that the keyboard is placed atop or next to a display surface of the second display; and modify a Graphical User Interface, GUI, provided by the second display in response to: i) the arrangement; ii) the position; and iii) an active application, by rendering a first bar including dynamically selected items associated with the active application on the second display along the keyboard. identify an arrangement of a second display relative to a first display; identify, using the one or more sensors, a position of a keyboard relative to the second display, by determining that the keyboard is placed atop or next to a display surface of the second display; and modify a Graphical User Interface, GUI, provided by the second display in response to: i) the arrangement; ii) the position; and iii) an active application, by rendering a first bar including dynamically selected items associated with the active application on the second display along the keyboard.
A blood purification device (100,100',200,200') for preventing or for treating disturbances of the acid-base balance, including acidosis or alkalosis, during an extracorporeal blood purification, comprising: an extracorporeal blood circuit (102,202) with a blood inflow (103,203) to a dialysis unit (105,205) for blood removed from a patient and a blood outflow (104,204) from the dialysis unit (105,205) for blood being guided back into the patient, wherein the dialysis unit (105,205) comprises an inflow (107,207) for a dialysis solution and a dialysate outflow (108,208), a control loop for controlling the acid-base balance of the blood, wherein bicarbonate is supplied to the blood by means of an aqueous bicarbonate-containing solution, wherein at least one measuring means (124,124a,224,224a) for measuring a blood buffer parameter is associated with the control loop, wherein the blood buffer parameter is selected from the group consisting of bicarbonate concentration and CO 2 partial pressure, and wherein a signal corresponding to the measured actual value of the blood buffer parameter can be supplied to a control apparatus (125,225), which regulates the actual value of the blood buffer parameter via the supply of bicarbonate to a predeterminable intended value or intended value range, and characterised by at least one pH-measuring means (150a,250a), which is arranged upstream of the dialysis unit (105,105) in the extracorporeal blood circuit (102,202), wherein a signal corresponding to the pH value can be supplied to an alarm apparatus (130,230), which triggers an alarm signal if a predeterminable pH value or a pH-value range is exceeded or undershot. an extracorporeal blood circuit (102,202) with a blood inflow (103,203) to a dialysis unit (105,205) for blood removed from a patient and a blood outflow (104,204) from the dialysis unit (105,205) for blood being guided back into the patient, wherein the dialysis unit (105,205) comprises an inflow (107,207) for a dialysis solution and a dialysate outflow (108,208), a control loop for controlling the acid-base balance of the blood, wherein bicarbonate is supplied to the blood by means of an aqueous bicarbonate-containing solution, wherein at least one measuring means (124,124a,224,224a) for measuring a blood buffer parameter is associated with the control loop, wherein the blood buffer parameter is selected from the group consisting of bicarbonate concentration and CO 2 partial pressure, and wherein a signal corresponding to the measured actual value of the blood buffer parameter can be supplied to a control apparatus (125,225), which regulates the actual value of the blood buffer parameter via the supply of bicarbonate to a predeterminable intended value or intended value range, and characterised by at least one pH-measuring means (150a,250a), which is arranged upstream of the dialysis unit (105,105) in the extracorporeal blood circuit (102,202), wherein a signal corresponding to the pH value can be supplied to an alarm apparatus (130,230), which triggers an alarm signal if a predeterminable pH value or a pH-value range is exceeded or undershot.
A system for communicating with an implantable medical device, comprising: an external controller containing at least one telemetry antenna (62a, 62b) integrated within a single housing for communicating data directly with the implantable medical device; and an external charging coil assembly containing a charging coil for providing power to the implantable medical device, wherein the assembly is attachable to and detachable from the external controller at a port on the external controller; wherein the telemetry antenna comprises two telemetry coils each wound around axes that are orthogonal. an external controller containing at least one telemetry antenna (62a, 62b) integrated within a single housing for communicating data directly with the implantable medical device; and an external charging coil assembly containing a charging coil for providing power to the implantable medical device, wherein the assembly is attachable to and detachable from the external controller at a port on the external controller; wherein the telemetry antenna comprises two telemetry coils each wound around axes that are orthogonal.